Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Purification + Nucleoside Analogues in Chronic Hepatitis B
NCT04518553Unknown
- Sponsor
- Shanghai Pudong Hospital
- Start
- Mar 2021
- Primary completion
- Sep 2023
01
Overview
Randomised, open-label trial (2 arms), sponsored by Shanghai Pudong Hospital. Primary endpoint: Concentration of HBV HBeAg is serologically negative at 2 years. Status: unknown.
Beyond the preview
Go deeper on NCT04518553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04518553.